Does ki-67 predict disease recurrence and poor prognosis in pancreatic neuroendocrine neoplasms?
Increasing tumor size and increasing Ki-67 staining both correlate with increased risk of disease recurrence and decreased OS. Designing a staging system that incorporates both of these clinical variables will enable better identification of patients at risk for recurrent pancreatic neuroendocrine neoplasms.
T-type calcium channel gene-CACNA1H might be a susceptibility gene to childhood absence epilepsy.